Overview

Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain

Status:
Completed
Trial end date:
2016-06-24
Target enrollment:
Participant gender:
Summary
The primary objective of this trial is to evaluate analgesic efficacy of Buprenorphine Sublingual (under the tongue) Spray compared with placebo in participants with postoperative pain after bunionectomy.
Phase:
Phase 3
Details
Lead Sponsor:
INSYS Therapeutics Inc
Treatments:
Buprenorphine